This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
Source-linked WNT16 Western blot protocol options, expected-band and isoform facts, troubleshooting for weak or shifted signal, and recommended anti-WNT16 WB antibodies. Everything you need to plan the experiment before you commit precious samples.
Expected bands, source-linked protocol options, controls and antibodies — the at-a-glance facts below, then the full design guide.
| Expected band | ~40.7 kDa | |
| Gel | 12–15% (standard starting point) | |
| Negative control | Suggested KO / knockdown lysate |
| PTM | Glycosylated + Cleaved | |
| Caveat | Glycosylation-state controls | |
| Gene-set association | MSigDB Hallmark membership | |
| Isoform | 2 isoform(s) |
The A03606-1 protocol combines labelled catalog values with standard starting conditions. Published comparisons retain their own sample, reagent and detection scope.
| Sample / lysate | Target-positive lysate and matched negative control (standard starting point) |
| Gel % | 12–15% (standard starting point) |
| Load | 20–30 µg total protein per lane; optimize for abundance (standard starting point) |
| Transfer | Standard semi-dry transfer; verify efficiency (standard starting point) |
| Membrane | 0.45 µm PVDF (standard starting point) |
| Blocking | 5% milk or 5% BSA in TBST (standard starting point) |
| Primary antibody | A03606-1; use the WB datasheet starting dilution (standard starting point) |
| Primary incubation | Overnight at 4 °C (standard starting point) |
| Secondary antibody | Species-matched HRP conjugate at validated dilution (standard starting point) |
| Secondary incubation | 1 h at room temperature (standard starting point) |
| Wash | 3 × 5 min in TBST (standard starting point) |
| Detection | ECL; bracket exposures to avoid saturation (standard starting point) |
WNT16 has a predicted 40.7 kDa precursor; signal-peptide cleavage, N-linked glycosylation, and isoforms may affect migration, but no empirical band is supplied.
| Band near 40.7 kDa | consistent with the predicted WNT16 precursor, pending band-identity controls |
| Band above 40.7 kDa | could reflect N-linked glycosylation at Asn143, Asn189, or Asn311; a visible shift is unproven |
| Band below 40.7 kDa | could reflect cleavage of the signal peptide at residues 1–29 |
| Several bands at different sizes | could include Wnt-16a and Wnt-16b, though distinct migration is unproven |
| Little or no band in whole-cell lysate | WNT16 may be found in the extracellular space or matrix |
| UniProt predicted precursor mass | 40.7 kDa provides the full-length reference size, not a measured band |
| N-linked glycosylation at Asn143, Asn189, and Asn311 | may increase apparent size; no visible shift is established |
| Signal peptide at residues 1–29 | cleavage makes the mature protein smaller than the precursor |
| Wnt-16a and Wnt-16b isoforms | may differ in apparent size; their relative sizes are unknown |
| Situation | Likely cause | Next action |
|---|---|---|
| No band in lysate | WNT16 is secreted and associated with extracellular space or matrix | check conditioned medium or an extracellular matrix fraction alongside lysate |
| Band higher than expected | N-linked glycosylation is possible at three documented sites | compare matched samples before and after N-glycan removal and confirm band identity |
| Band lower than expected | signal-peptide cleavage can reduce size relative to the precursor | check antibody epitope coverage and confirm the band with WNT16 depletion |
| Broad smear instead of sharp band | variable N-linked glycosylation is possible, but a smear is not established | compare matched samples before and after N-glycan removal |
| Multiple bands | Wnt-16a and Wnt-16b are annotated isoforms, but separate bands are unproven | use WNT16 depletion to identify specific bands |
| Weak or no signal | secreted WNT16 may be scarce in the tested cell fraction | test conditioned medium or extracellular matrix material with a positive control |
Comprehensive Human Protein Atlas IHC scoring per tissue. Rows are taken directly from the HPA tissue chart — click any row's HPA link to view the source.
| Tissue | Cell type | Level | Evidence | Source |
|---|---|---|---|---|
| No high/medium HPA tissues identified in the supplied evidence. | ||||
| Tissue | Cell type | Level | Evidence | Source |
|---|---|---|---|---|
| No lower-expression tissue rows available in the supplied evidence. | ||||
Deeper troubleshooting and optimisation questions for WNT16, answered from its protein features.
Catalog antibodies with Western blot application and product-specific WB images. Evaluate suitability with the reported sample, controls and experimental conditions.
Two the supplier anti-WNT16 antibodies have supplied Western blot images: A03606-1 in CEM cell lysate and M03606 in human SH-SY5Y and U251 cell lysates plus rat and mouse kidney lysates. No publication evidence is supplied.
Which to pick: For human CEM lysate, A03606-1 has a WB image. M03606 lists human, mouse, and rat reactivity; its WB image includes samples from all three species and reports an approximately 41 kDa band.